2021-08-012024-05-17https://scholars.lib.ntu.edu.tw/handle/123456789/690416Dissecting the Differential Immunomodulatory Effects of Anti-Angiogenic Tyrosine Kinase Inhibitors toward Optimal Immunotherapy for Hepatocellular Carcinoma( I )